| Lung Cancer: Textbook for General Practitioners Contributor(s): Hansen, Heine H. (Editor) |
|
 |
ISBN: 3540530754 ISBN-13: 9783540530756 Publisher: Springer OUR PRICE: $52.24 Product Type: Paperback - Other Formats Published: October 1990 |
| Additional Information |
| BISAC Categories: - Medical | Oncology - General - Medical | Pulmonary & Thoracic Medicine |
| Dewey: 616.994 |
| LCCN: 90010261 |
| Series: European Commission Series for General Practitioners |
| Physical Information: 0.16" H x 8.25" W x 11" (0.42 lbs) 58 pages |
| Descriptions, Reviews, Etc. |
| Publisher Description: The "Europe against Cancer" programme has, from its inception, emphasised the key role which general practitioners must play in the actions necessary to achieve its aim of reduc- ing the incidence and the mortality from cancer in the European Community. General practitioners, because of their day-to-day direct and continuing contact with patients, playa role not only in primary prevention and education of patients, but also in motivating their patients to accept secondary prevention and screening, some of it carried out by general practitioners themselves. These preventive activities are in addition to their traditional role in the care and management of patients with cancer at home, and increas- ingly, their role in active treatment. In view of the importance of the general practitioner in the "Europe against Cancer" pro- gramme, the European Commission, with a view to providing general practitioners with up-to-date useful information, has sponsored the production of this series of publications on organ based cancers, especially written for general practitioners. MICHEL RICHONNIER Coordinator ofthe "Europe against Cancer" programme, Commission ofthe European Communities, Brussels Preface To decrease the death rate of lung cancer is today one of the major challenges of medical doctors all over the world. In Europe alone, one person is dying of lung cancer every two minutes. Accordingly, most physicians will regularly in their career be confronted with a patient being either suspect of or having a lung cancer. |